In contrast, participants with increasing TNF+ IgM‐only MBC displayed a significantly longer time before MS conversion compared to those with decreasing ratios of TNF+ IgM‐only MBC over the same period of time (Figure 6c). This evidence concerns the gene CD40LG and myeloid sarcoma.